Antimicrobial proteins: intestinal guards to protect against liver disease.


Journal

Journal of gastroenterology
ISSN: 1435-5922
Titre abrégé: J Gastroenterol
Pays: Japan
ID NLM: 9430794

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 02 10 2018
accepted: 19 10 2018
pubmed: 6 11 2018
medline: 19 6 2020
entrez: 5 11 2018
Statut: ppublish

Résumé

Alterations of gut microbes play a role in the pathogenesis and progression of many disorders including liver and gastrointestinal diseases. Both qualitative and quantitative changes in gut microbiota have been associated with liver disease. Intestinal dysbiosis can disrupt the integrity of the intestinal barrier leading to pathological bacterial translocation and the initiation of an inflammatory response in the liver. In order to sustain symbiosis and protect from pathological bacterial translocation, antimicrobial proteins (AMPs) such as a-defensins and C-type lectins are expressed in the gastrointestinal tract. In this review, we provide an overview of the role of AMPs in different chronic liver disease such as alcoholic steatohepatitis, non-alcoholic fatty liver disease, and cirrhosis. In addition, potential approaches to modulate the function of AMPs and prevent bacterial translocation are discussed.

Identifiants

pubmed: 30392013
doi: 10.1007/s00535-018-1521-8
pii: 10.1007/s00535-018-1521-8
pmc: PMC6391196
mid: NIHMS1511511
doi:

Substances chimiques

Bacterial Proteins 0
Defensins 0
Lectins, C-Type 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

209-217

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA020703
Pays : United States
Organisme : BLRD VA
ID : I01 BX004594
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA024726
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA021856
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA024726
Pays : United States
Organisme : BLRD VA
ID : I01 BX002213
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026939
Pays : United States

Références

J Hepatol. 2000 May;32(5):742-7
pubmed: 10845660
J Hepatol. 2001 Jan;34(1):32-7
pubmed: 11211904
World J Gastroenterol. 1999 Oct;5(5):391-396
pubmed: 11819475
J Hepatol. 2002 Oct;37(4):456-62
pubmed: 12217598
J Gastroenterol. 2002;37(9):726-31
pubmed: 12375146
J Surg Res. 2003 May 15;111(2):209-14
pubmed: 12850464
Infect Immun. 2004 Oct;72(10):5750-8
pubmed: 15385474
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3920-5
pubmed: 16473946
Gastroenterology. 2006 May;130(6):1886-900
pubmed: 16697751
Science. 2006 Aug 25;313(5790):1126-30
pubmed: 16931762
J Exp Med. 2007 Aug 6;204(8):1891-900
pubmed: 17635956
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5
pubmed: 17699621
J Nutr. 2007 Nov;137(11 Suppl):2503S-2506S
pubmed: 17951493
Clin Exp Immunol. 2008 Mar;151(3):528-35
pubmed: 18190603
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15064-9
pubmed: 18806221
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20858-63
pubmed: 19075245
Hepatology. 2009 Jun;49(6):1877-87
pubmed: 19291785
Gut. 2009 May;58(5):704-20
pubmed: 19359436
J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S16-8
pubmed: 20535027
Nature. 2010 Jul 15;466(7304):334-8
pubmed: 20631792
Hepatology. 2010 Dec;52(6):2044-52
pubmed: 20979050
Hepatology. 2011 Jan;53(1):96-105
pubmed: 21254165
Nat Immunol. 2011 May;12(5):383-90
pubmed: 21502992
Nature. 2011 Jun 15;474(7351):327-36
pubmed: 21677749
Clin Gastroenterol Hepatol. 2012 Feb;10(2):117-25
pubmed: 21893127
Am J Pathol. 2011 Dec;179(6):2885-93
pubmed: 21986443
Science. 2011 Oct 14;334(6053):255-8
pubmed: 21998396
Eur J Clin Invest. 2012 Apr;42(4):439-46
pubmed: 22023490
Hepatology. 2012 Apr;55(4):1154-63
pubmed: 22095436
Nat Immunol. 2011 Nov 20;13(2):144-51
pubmed: 22101730
J Hepatol. 2012 Jun;56(6):1283-92
pubmed: 22326468
Science. 2012 Jun 8;336(6086):1314-7
pubmed: 22674328
J Appl Microbiol. 2012 Dec;113(6):1491-7
pubmed: 22905671
Gastroenterology. 1990 Feb;98(2):414-23
pubmed: 2295397
Hepatology. 2013 Feb;57(2):601-9
pubmed: 23055155
Ann Hepatol. 2013 Mar-Apr;12(2):301-7
pubmed: 23396742
J Hepatol. 2013 Jun;58(6):1125-32
pubmed: 23402745
Hepatology. 2013 Jul;58(1):108-19
pubmed: 23408358
Nat Protoc. 2013 Mar;8(3):627-37
pubmed: 23449255
J Hepatol. 2013 Jul;59(1):160-8
pubmed: 23511777
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760
Nutr Rev. 2013 Jul;71(7):483-99
pubmed: 23815146
Immunity. 2013 Aug 22;39(2):372-85
pubmed: 23973224
J Hepatol. 2014 Jan;60(1):197-209
pubmed: 23993913
Cell. 2013 Dec 19;155(7):1451-63
pubmed: 24315484
J Gastroenterol Hepatol. 2014 Jun;29(6):1292-8
pubmed: 24372861
Gastroenterology. 2014 May;146(6):1513-24
pubmed: 24440671
BMC Gastroenterol. 2014 Feb 24;14:40
pubmed: 24564202
Cell. 2014 Mar 27;157(1):142-50
pubmed: 24679532
ISME J. 2014 Oct;8(10):2116-30
pubmed: 24694712
Gut. 2014 Sep;63(9):1513-21
pubmed: 24833634
Hepatology. 2015 Mar;61(3):883-94
pubmed: 25251280
World J Gastroenterol. 2014 Nov 14;20(42):15624-31
pubmed: 25400446
Gastroenterology. 2015 Jan;148(1):30-6
pubmed: 25447847
World J Gastroenterol. 2014 Dec 7;20(45):16795-810
pubmed: 25492994
Immunity. 2015 Jan 20;42(1):28-39
pubmed: 25607457
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
Eur J Gastroenterol Hepatol. 2015 Jul;27(7):840-5
pubmed: 26043290
Expert Rev Gastroenterol Hepatol. 2015;9(8):1069-76
pubmed: 26088524
Cell Mol Gastroenterol Hepatol. 2015 Mar;1(2):222-232
pubmed: 26405687
Hepatology. 2016 Mar;63(3):764-75
pubmed: 26600078
Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:11-26
pubmed: 26618922
Gut. 2016 May;65(5):830-9
pubmed: 26642859
J Hepatol. 2016 May;64(5):1049-1057
pubmed: 26723896
Ann Gastroenterol. 2016 Jan-Mar;29(1):63-70
pubmed: 26751578
Cell Host Microbe. 2016 Feb 10;19(2):227-39
pubmed: 26867181
G Ital Cardiol (Rome). 2016 Jan;17(1):11-4
pubmed: 26901254
Clin Liver Dis. 2016 May;20(2):263-75
pubmed: 27063268
Nat Med. 2016 Jun;22(6):598-605
pubmed: 27158904
Int J Obes (Lond). 2016 Sep;40(9):1424-34
pubmed: 27163748
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25
pubmed: 27273168
Gastroenterology. 2016 Oct;151(4):733-746.e12
pubmed: 27342212
Front Physiol. 2016 Nov 15;7:498
pubmed: 27895587
Semin Liver Dis. 2016 Sep;36(4):331-339
pubmed: 27997973
Curr Opin Gastroenterol. 2017 May;33(3):128-133
pubmed: 28257306
Cell Metab. 2017 May 2;25(5):1054-1062.e5
pubmed: 28467925
J Clin Invest. 2017 Jun 30;127(7):2829-2841
pubmed: 28530644
Exp Mol Med. 2017 May 26;49(5):e338
pubmed: 28546564
Ann Gastroenterol. 2017;30(5):486-497
pubmed: 28845103
Gastroenterol Hepatol (N Y). 2014 Aug;10(8):519-521
pubmed: 28845144
Clin Sci (Lond). 2018 Jan 19;132(2):199-212
pubmed: 29352076
Hepatol Commun. 2018 Feb 28;2(4):393-406
pubmed: 29619418
Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):397-411
pubmed: 29748586
J Hepatol. 2018 Oct;69(4):886-895
pubmed: 29803899
Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):641-656
pubmed: 29806487
Gut. 2018 Nov 17;:
pubmed: 30448775
Scand J Gastroenterol. 1997 Sep;32(9):942-6
pubmed: 9299675

Auteurs

Tim Hendrikx (T)

Department of Medicine, University of California San Diego, La Jolla, CA, USA.

Bernd Schnabl (B)

Department of Medicine, University of California San Diego, La Jolla, CA, USA. beschnabl@ucsd.edu.
Department of Medicine, VA San Diego Healthcare System, San Diego, CA, USA. beschnabl@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH